# Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder

> **NCT00374543** · PHASE4 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 3 (actual)

## Conditions studied

- Generalized Anxiety Disorder
- Bipolar Disorder

## Interventions

- **DRUG:** Ziprasidone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00374543
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** 2007-10
- **Final completion:** 2008-11
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Recruitment goal could not be achieved
- **Last updated:** 2014-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374543, "Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00374543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*